According to Emergen Research, the global single-cell sequencing market size was USD 1,294.01 million in 2020 and is expected to reach USD 3,679.65 million in 2028 and register a revenue CAGR of 13.9% during the forecast period, 2021-2028.
Emergen Research has published its latest report titled “Single-cell Sequencing Market, By Product (Consumables, Instruments), By Workflow (Single Cell Isolation, Sample Preparation, Genomic Sequencing), By Technology (Flow Cytometry, Next-generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, Others), By Application (Research Applications, Medical Applications), By End-use (Academic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Cell Banks & IVF Centers, Others), and By Region, Forecast to 2028”
According to Emergen Research, the global single-cell sequencing market size was USD 1,294.01 million in 2020 and is expected to reach USD 3,679.65 million in 2028 and register a revenue CAGR of 13.9% during the forecast period, 2021-2028.
Market Dynamics:
Major factors supporting revenue growth of the global single-cell sequencing market include the rising prevalence of cancer and various neurological and immunological diseases worldwide, rise in research & development activities in the pharmaceutical and biotechnology sectors, and technological advances in single-cell sequencing techniques. Rising demand for personalized medicine, increasing public and private investments in stem cell research, increasing focus on development of cutting-edge medical diagnostics, and rapid adoption of technologically advanced single-cell sequencing and analysis devices are among the other factors expected to boost the global market revenue growth over the forecast period.
Single-cell sequencing technology primarily finds application in identification and analysis of rare cells and disease pathogenesis. Increasing applications of the technology in cell differentiation/reprogramming, genomic variation, subpopulation characterization, and prenatal diagnosis, and increasing R&D activities in fields of oncology, immunology, neurobiology, microbiology, genomics, epigenomics, and transcriptomics are other important factors contributing to the global single-cell sequencing market revenue growth.
Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.emergenresearch.com/request-sample-form/140
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Consumables Segment Accounted for Largest Revenue Share in 2020:
Based on product, the global single-cell sequencing market is primarily segmented into consumables and instruments. The consumables segment dominated other segments in terms of revenue share in the global market in 2020. Increasing applications of consumables in genomic research activities including genetic exploration, isolation of RNA and DNA, and exosome analysis are expected to significantly drive revenue growth of this segment.
Academic & Research Laboratories Segment to Account for Fastest Revenue Growth Rate:
Based on end-use, the global single-cell sequencing market is segmented into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, cell banks & IVF centers, and others. The academic & research laboratories segment is projected to register the fastest revenue growth rate in the global market over the forecast period. Rising public and private investments in pharmaceutical and biotechnological research programs and increasing collaborations between life science companies and academic & research institutes are among the major factors driving the revenue growth of this segment.
Buy Your Copy Now (Customized Report Delivered as per Your Specific Requirement)@ https://www.emergenresearch.com/select-license/140
North America Accounted for Largest Revenue Share in 2020:
Among the regional markets, the North America single-cell sequencing market accounted for the largest revenue share in the global market in 2020. Key factors such as rising prevalence of cancer and various neurological and immunological disorders, growing need for personalized medicine, increasing government and private investments in pharmaceutical and biotechnological R&D activities, and presence of leading market players in the region, including Becton, Dickinson and Company, Thermo Fisher Scientific, and Danaher Corporation, are key factors driving the regional market revenue growth.
Major Companies in the Global Single-cell Sequencing Market Include:
- Becton, Dickinson and Company
- Danaher Corporation
- Merck KGAA
- QIAGEN N.V.
- Thermo Fisher Scientific
- 10x Genomics
- Promega Corporation
- Illumina, Inc.
- Bio-Rad Laboratories
- Fluidigm Corporation
- Agilent Technologies, Inc.
- Tecan Group Ltd.
- Sartorius AG
- Luminex Corporation
- Takara Bio
- Fluxion Biosciences
- BioMérieux SA
- Oxford Nanopore Technologies
- Cytek Biosciences
- Corning Incorporated
- Apogee Flow Systems Ltd.
- NanoCellect Biomedical
- Rarecyte Inc
- On-chip Biotechnologies Co., Ltd.
Click on the link to read key highlights of the report and look at projected trends for years to come: https://www.emergenresearch.com/industry-report/single-cell-sequencing-market
For the purpose of this report, Emergen Research has segmented the global single-cell sequencing market based on product, workflow, technology, application, end-use, and region:
Product Outlook (Revenue, USD Million; 2018–2028)
- Consumables
- Reagents
- Assay Kits
- Instruments
- Microscopes
- Hemocytometers
- Flow Cytometers
- NGS Systems
- PCR Systems
- High Content Screening Systems
- Cell Microarrays
- Single Live Cell Imaging
- Automated Cell Counters
Workflow Outlook (Revenue, USD Million; 2018–2028)
- Single Cell Isolation
- Sample Preparation
- Genomic Sequencing
Technology Outlook (Revenue, USD Million; 2018–2028)
- Flow Cytometry
- Next-generation Sequencing
- Polymerase Chain Reaction
- Microscopy
- Mass Spectrometry
- Others
Application Outlook (Revenue, USD Million; 2018–2028)
- Research Applications
- Oncology
- Immunology
- Neurology
- Stem Cell
- Others
- Medical Applications
- Non-invasive Prenatal Diagnosis
- In-vitro Fertilization
- Circulating Tumor Cell Detection
End-use Outlook (Revenue, USD Million; 2018–2028)
- Academic & Research Laboratories
- Biotechnology & Pharmaceutical Companies
- Hospitals & Diagnostic Laboratories
- Cell Banks & IVF Centers
- Others
Region Outlook (Revenue, USD Million; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Reasons to buy the report:
- This study segments the Single-cell Sequencing market and derives the precise valuation of the overall, as well as segment-based, market across different industry verticals, geographies, and products.
- The report will help participants understand the trajectory of the progress of the market and provide information on key drivers, restraints, challenges, threats, and opportunities for the growth of the Single-cell Sequencing sectors.
- This Single-cell Sequencing report would allow readers to be well-versed with the existing competition and gain more insights to improve their standing in the worldwide business. The competitive landscape considers the dominant competitors, along with product launches and technological advancements, strategic expansions, mergers and acquisitions, and procurement strategies implemented by key players in the Single-cell Sequencing market.
Key features of the report:
- To study the key aspects impacting the Single-cell Sequencing market size.
- To identify growth prospects in the Single-cell Sequencing market.
- To analyze the Single-cell Sequencing market segments and deduce the dominant trends observed in the industry.
- To examine the Single-cell Sequencing market by investigating the available products, market share, and value proposition of the products.
- To analyze the industry by assessing the scope and application of the Single-cell Sequencing market and highlight the growth of each application.
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2020-2030
Chapter 3. Key Insights
Chapter 4. Single-cell Sequencing Market Segmentation & Impact Analysis
4.1. Single-cell Sequencing Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers’ analysis
4.2.3. Market restraints analysis
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Continued…
Explore Complete Table of Content@ https://www.emergenresearch.com/industry-report/single-cell-sequencing-market/toc
Latest Published Reports by Emergen Research:
Targeted Therapeutics Market, By Therapy (Monoclonal Antibodies, Small Molecule Inhibitors), By Disease Indication, By End-use, and By Region Forecast to 2028.
Dermal Regeneration Template Market By Type (Fortified Type, Fenestrated Type, Single Layer Type), By Application (Massively Burned Patients, Acutely Excised Wounds, Chronic Wounds, Others), By End Use (Hospital, Wound Care, Others) By Region Forecast to 2028.
Telehealth Market, By Type (Tele-Home and Tele-Hospital), By Component, By Deployment Model (Web & Cloud-based and On-premises), By Application, By End-user, and By Region Forecast to 2028.
Augmented Reality and Virtual Reality in Healthcare Market By Technology (Augmented Reality, Virtual Reality), By Component (Hardware, Software, Services), By Application (Surgery, Training & Education), By End-use (Hospitals, Clinics), and By Region Forecast to 2030.
Leadless Pacemaker Systems Market, By Product Type, By Application (Atrial Fibrillation, Sinus Node Dysfunction, Atrioventricular Block and Others), By Technology, By End-use, and By Region Forecast to 2028.
Biodefense Market Size, Share, Trends, By Product Type (COVID-19 Vaccine, Anthrax Vaccine, Others), By Biothreat Detection Device Type, By End-Use, and By Region Forecast to 2028.
Cryotherapy Market By Product (Localized Cryotherapy Devices, Cryosurgery Devices, Cryochambers & Cryosaunas, Gas Cylinders, Others), By Therapy (Icepack Therapy, Cryosurgery, Chamber Therapy), By Application, By End-Use, and By Region Forecast to 2028
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Our Press Release@ https://www.emergenresearch.com/press-release/global-single-cell-sequencing-market